- Investing Ideas
- Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies
Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
42
Companies with a Value score of at least 3, ordered by Value score
42 companies
Kuros Biosciences
Market Cap: CHF 928.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.04
7D
-2.1%
1Y
-15.2%
Gerresheimer
Market Cap: CHF 913.9m
Provides drug containment solutions in Germany and internationally.
GXI
CHF 25.28
7D
-1.7%
1Y
-66.6%
Evotec
Market Cap: CHF 609.7m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
CHF 4.63
7D
0%
1Y
n/a
Viatris
Market Cap: CHF 20.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
CHF 14.24
7D
-2.3%
1Y
n/a
Bristol-Myers Squibb
Market Cap: CHF 134.6b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
CHF 51.50
7D
-1.0%
1Y
n/a
Joincare Pharmaceutical Group IndustryLtd
Market Cap: US$18.0b
Joincare Pharmaceutical Group Industry Co.,Ltd.
JCARE
US$8.00
7D
0%
1Y
0%
Novavax
Market Cap: CHF 1.3b
A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
NVAX
CHF 6.14
7D
2.0%
1Y
n/a
Basilea Pharmaceutica
Market Cap: CHF 628.5m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 51.40
7D
-1.5%
1Y
-4.5%
AstraZeneca
Market Cap: CHF 186.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
000982352
CHF 124.91
7D
-12.3%
1Y
3.1%
Santhera Pharmaceuticals Holding
Market Cap: CHF 227.8m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 15.50
7D
7.3%
1Y
14.8%
Jazz Pharmaceuticals
Market Cap: CHF 17.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
J7Z
CHF 209.03
7D
-0.5%
1Y
n/a
Roche Holding
Market Cap: CHF 291.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 364.70
7D
3.2%
1Y
46.4%
Novartis
Market Cap: CHF 236.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 125.18
7D
-1.3%
1Y
34.5%
Tecan Group
Market Cap: CHF 2.4b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 191.80
7D
2.6%
1Y
23.5%
Qiagen
Market Cap: CHF 9.2b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QIA
CHF 50.36
7D
0%
1Y
0%
Illumina
Market Cap: CHF 20.6b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
CHF 129.57
7D
0%
1Y
n/a
Gilead Sciences
Market Cap: CHF 163.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
CHF 105.02
7D
0.04%
1Y
n/a
Orion Oyj
Market Cap: CHF 11.5b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
OFK
CHF 75.93
7D
-0.9%
1Y
n/a
Sanofi
Market Cap: CHF 89.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
CHF 73.20
7D
0%
1Y
n/a
Roche Holding
Market Cap: CHF 291.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
RO
CHF 368.40
7D
2.7%
1Y
41.5%
Bachem Holding
Market Cap: CHF 5.5b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 72.75
7D
-5.5%
1Y
8.2%
MindMaze Therapeutics Holding
Market Cap: CHF 36.0m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.26
7D
30.8%
1Y
n/a
MannKind
Market Cap: CHF 1.3b
A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.
NNFN
CHF 3.30
7D
3.0%
1Y
n/a
Bayer
Market Cap: CHF 48.6b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
CHF 44.18
7D
0%
1Y
n/a
Formycon
Market Cap: CHF 328.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
CHF 17.39
7D
-1.3%
1Y
n/a
Idorsia
Market Cap: CHF 1.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 6.01
7D
-3.1%
1Y
115.8%
Grifols
Market Cap: CHF 6.1b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
OZTA
CHF 9.51
7D
-1.9%
1Y
n/a
Newron Pharmaceuticals
Market Cap: CHF 255.1m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 12.30
7D
4.2%
1Y
71.1%
Novartis
Market Cap: CHF 236.6b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVNEE
CHF 125.08
7D
-1.8%
1Y
34.5%
Merck KGaA
Market Cap: CHF 63.0b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MER
CHF 125.25
7D
0%
1Y
n/a
CRISPR Therapeutics
Market Cap: CHF 5.1b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
1CG
CHF 39.10
7D
2.9%
1Y
-13.1%
Siegfried Holding
Market Cap: CHF 3.9b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
142932682
CHF 93.00
7D
0%
1Y
n/a
Johnson & Johnson
Market Cap: CHF 614.4b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
CHF 206.60
7D
-6.1%
1Y
49.5%
Pfizer
Market Cap: CHF 144.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
CHF 20.53
7D
-0.7%
1Y
n/a
Amgen
Market Cap: CHF 220.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
000907582
CHF 314.13
7D
-2.7%
1Y
n/a
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 60.90
7D
0.5%
1Y
9.3%